According to a recent analysis by market research firm Numerator, Ozempic users have slashed snack buying at supermarkets.

The food industry is still uneasy about the American anti-obesity craze, which is being fueled by GLP-1-based weight-loss medications like Wegovy and Mounjaro, which are manufactured by Novo Nordisk and Eli Lilly. This is because a recent study, which was cited by Morgan Stanley, indicates that households taking these medications are spending less money at the grocer...